XML 33 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY AND BENEFIT PLANS
9 Months Ended
Sep. 28, 2013
STOCKHOLDERS' EQUITY AND BENEFIT PLANS  
STOCKHOLDERS' EQUITY AND BENEFIT PLANS

6. STOCKHOLDERS’ EQUITY AND BENEFIT PLANS

 

Common Stock Repurchase Programs. Purchases of the Company’s common stock are made from time to time pursuant to its repurchase programs, subject to market conditions and at prevailing market prices, through the open market. Repurchased shares of common stock are recorded at cost and become authorized but unissued shares which may be issued in the future for general corporate or other purposes. The Company may terminate or limit its stock repurchase program at any time. In the event the repurchased shares are cancelled, the Company accounts for retirements by allocating the repurchase price to common stock, additional paid-in capital and retained earnings. The repurchase price allocation is based upon the equity contribution associated with historical issuances. The repurchase programs are conducted pursuant to Rule 10b-18 of the Exchange Act.

 

During the Year To Date Period, the Company effectively retired 4.3 million shares of common stock repurchased under its repurchase programs. The effective retirement of repurchased common stock decreased common stock by $42,700, additional paid-in capital by $6.2 million, retained earnings by $447.7 million and treasury stock by $454.0 million. At December 29, 2012 and September 28, 2013, all treasury stock had been effectively retired. As of September 28, 2013, the Company had $614.6 million of repurchase authorizations remaining under the combined repurchase plans.

 

The following table reflects the Company’s common stock repurchase activity for the periods indicated (in millions):

 

 

 

 

 

 

 

For the 13 Weeks Ended
September 28, 2013

 

For the 39 Weeks Ended
September 28, 2013

 

Fiscal Year Authorized

 

Dollar Value
Authorized

 

Termination Date

 

Number of
Shares
Repurchased

 

Dollar Value
Repurchased

 

Number of
Shares
Repurchased

 

Dollar Value
Repurchased

 

2012

 

$

1,000.0

 

December 2016

 

2.0

 

$

228.2

 

3.9

 

$

415.4

 

2010

 

$

30.0

 

None

 

0.0

 

$

0.0

 

0.0

 

$

0.0

 

2010

 

$

750.0

 

December 2013(1)

 

0.0

 

$

0.0

 

0.4

 

$

38.6

 

 

(1)         In the first quarter of fiscal year 2013, the Company completed this repurchase plan.

 

Stock-Based Compensation Plans. The Company accounts for stock-based compensation in accordance with the provisions of ASC 718, Compensation-Stock Compensation (“ASC 718”), using the Black-Scholes option pricing model to determine the fair value of stock options and stock appreciation rights at the date of grant. Grants under the Company’s stock-based compensation plans generally include: (i) stock options, restricted stock and restricted stock units for its international employees, (ii) restricted stock units for its non-employee directors and (iii) stock appreciation rights, restricted stock and restricted stock units for its U.S.-based employees.

 

The following table summarizes stock options and stock appreciation rights activity during the Third Quarter:

 

Stock Options and Stock Appreciation Rights

 

Number of
Shares

 

Weighted-
Average
Exercise Price

 

Weighted-
Average
Remaining
Contractual
Term
(Years)

 

Aggregate
Intrinsic
Value

 

 

 

in thousands

 

 

 

 

 

in thousands

 

Outstanding at June 29, 2013

 

823

 

$

72.14

 

6.3

 

$

31,815

 

Granted

 

3

 

108.15

 

 

 

 

 

Exercised

 

(49

)

39.05

 

 

 

3,934

 

Forfeited or expired

 

(28

)

101.50

 

 

 

 

 

Outstanding at September 28, 2013

 

749

 

73.42

 

6.2

 

34,909

 

Exercisable at September 28, 2013

 

451

 

$

56.95

 

5.4

 

$

27,838

 

 

The aggregate intrinsic value shown in the table above is before income taxes and is based on (i) the exercise price for outstanding and exercisable options/rights at September 28, 2013 and (ii) the fair market value of the Company’s common stock on the exercise date for options/rights that were exercised during the Third Quarter.

 

Stock Options and Stock Appreciation Rights Outstanding and Exercisable. The following table summarizes information with respect to stock options and stock appreciation rights outstanding and exercisable at September 28, 2013:

 

 

 

Stock Options Outstanding

 

Stock Options Exercisable

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

Weighted-

 

Average

 

 

 

Weighted-

 

 

 

 

 

Average

 

Remaining

 

 

 

Average

 

 

 

Number of

 

Exercise

 

Contractual

 

Number of

 

Exercise

 

Range of Exercise Prices

 

Shares

 

Price

 

Term (Years)

 

Shares

 

Price

 

 

 

in thousands

 

 

 

 

 

in thousands

 

 

 

$13.65 - $21.51

 

89

 

$

15.38

 

4.6

 

68

 

$

15.93

 

$21.51 - $34.59

 

82

 

28.70

 

3.1

 

82

 

28.70

 

$34.59 - $67.10

 

85

 

39.66

 

5.9

 

85

 

39.66

 

$67.10 - $106.40

 

126

 

81.04

 

7.5

 

71

 

80.85

 

$106.40 - $131.46

 

184

 

128.08

 

8.3

 

66

 

128.08

 

Total

 

566

 

$

72.16

 

6.4

 

372

 

$

56.42

 

 

 

 

Stock Appreciation Rights Outstanding

 

Stock Appreciation Rights Exercisable

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

Weighted-

 

Average

 

 

 

Weighted-

 

 

 

 

 

Average

 

Remaining

 

 

 

Average

 

 

 

Number of

 

Exercise

 

Contractual

 

Number of

 

Exercise

 

Range of Exercise Prices

 

Shares

 

Price

 

Term (Years)

 

Shares

 

Price

 

 

 

in thousands

 

 

 

 

 

in thousands

 

 

 

$13.65 - $21.51

 

23

 

$

13.65

 

3.5

 

9

 

$

13.65

 

$21.51 - $34.59

 

20

 

29.13

 

2.3

 

20

 

29.13

 

$34.59 - $67.10

 

24

 

41.31

 

4.7

 

21

 

39.46

 

$67.10 - $106.40

 

69

 

92.37

 

6.7

 

11

 

81.23

 

$106.40 - $131.46

 

47

 

126.40

 

6.2

 

18

 

127.95

 

Total

 

183

 

$

77.29

 

5.4

 

79

 

$

59.39

 

 

Restricted Stock and Restricted Stock Units. The following table summarizes restricted stock and restricted stock unit activity during the Third Quarter:

 

 

 

 

 

Weighted-Average

 

 

 

Number of

 

Grant Date Fair

 

Restricted Stock and Restricted Stock Units 

 

Shares

 

Value

 

 

 

in thousands

 

 

 

Nonvested at June 29, 2013

 

221

 

$

96.47

 

Granted

 

19

 

110.91

 

Vested

 

(6

)

69.73

 

Forfeited

 

(9

)

91.76

 

Nonvested at September 28, 2013

 

225

 

$

98.61

 

 

The total fair value of restricted stock and restricted stock units vested during the Third Quarter was approximately $0.6 million.

 

Accumulated Other Comprehensive Income. The following table illustrates changes in the balances of each component of accumulated other comprehensive income, net of taxes (in thousands):

 

 

 

For the 13 Weeks Ended September 28, 2013

 

 

 

Currency
Translation
Adjustments

 

Securities
Available for
Sale

 

Forward
Contracts

 

Interest Rate
Swap

 

Total

 

Beginning balance

 

$

13,328

 

$

(558

)

$

4,044

 

$

0

 

$

16,814

 

Other comprehensive income (loss) before reclassifications, net of tax benefit of $4,457

 

19,277

 

558

 

(4,733

)

(922

)

14,180

 

 

 

 

 

 

 

 

 

 

 

 

 

Amounts reclassed from accumulated other comprehensive income, net of tax expense of $31

 

0

 

0

 

326

 

(290

)

36

 

 

 

 

 

 

 

 

 

 

 

 

 

Total other comprehensive income (loss)

 

19,277

 

558

 

(5,059

)

(632

)

14,144

 

 

 

 

 

 

 

 

 

 

 

 

 

Ending balance

 

$

32,605

 

$

0

 

$

(1,015

)

$

(632

)

$

30,958

 

 

 

 

For the 13 Weeks Ended September 29, 2012

 

 

 

Currency
Translation
Adjustments

 

Securities
Available for
Sale

 

Forward
Contracts

 

Interest Rate
Swap

 

Total

 

Beginning balance

 

$

13,343

 

$

(417

)

$

4,581

 

$

0

 

$

17,507

 

Other comprehensive income (loss) before reclassifications, net of tax benefit of $1,849

 

12,249

 

(4

)

(121

)

0

 

12,124

 

 

 

 

 

 

 

 

 

 

 

 

 

Amounts reclassed from accumulated other comprehensive income, net of tax expense of $973

 

0

 

0

 

1,862

 

0

 

1,862

 

 

 

 

 

 

 

 

 

 

 

 

 

Total other comprehensive income (loss)

 

12,249

 

(4

)

(1,983

)

0

 

10,262

 

 

 

 

 

 

 

 

 

 

 

 

 

Ending balance

 

$

25,592

 

$

(421

)

$

2,598

 

$

0

 

$

27,769

 

 

 

 

For the 39 Weeks Ended September 28, 2013

 

 

 

Currency
Translation
Adjustments

 

Securities
Available for
Sale

 

Forward
Contracts

 

Interest Rate
Swap

 

Total

 

Beginning balance

 

$

30,181

 

$

(475

)

$

(946

)

$

0

 

$

28,760

 

Other comprehensive income (loss) before reclassifications, net of tax benefit of $651

 

2,424

 

475

 

1,055

 

(922

)

3,032

 

 

 

 

 

 

 

 

 

 

 

 

 

Amounts reclassed from accumulated other comprehensive income, net of tax expense of $623

 

0

 

0

 

1,124

 

(290

)

834

 

 

 

 

 

 

 

 

 

 

 

 

 

Total other comprehensive income (loss)

 

2,424

 

475

 

(69

)

(632

)

2,198

 

 

 

 

 

 

 

 

 

 

 

 

 

Ending balance

 

$

32,605

 

$

0

 

$

(1,015

)

$

(632

)

$

30,958

 

 

 

 

For the 39 Weeks Ended September 29, 2012

 

 

 

Currency
Translation
Adjustments

 

Securities
Available for
Sale

 

Forward
Contracts

 

Interest Rate
Swap

 

Total

 

Beginning balance

 

$

18,953

 

$

(446

)

$

3,673

 

$

0

 

$

22,180

 

Other comprehensive income (loss) before reclassifications, net of tax expense of $133

 

6,639

 

25

 

3,090

 

0

 

9,754

 

 

 

 

 

 

 

 

 

 

 

 

 

Amounts reclassed from accumulated other comprehensive income, net of tax expense of $2,138

 

0

 

0

 

4,165

 

0

 

4,165

 

 

 

 

 

 

 

 

 

 

 

 

 

Total other comprehensive income (loss)

 

6,639

 

25

 

(1,075

)

0

 

5,589

 

 

 

 

 

 

 

 

 

 

 

 

 

Ending balance

 

$

25,592

 

$

(421

)

$

2,598

 

$

0

 

$

27,769

 

 

See “Note 8—Derivatives and Risk Management” for additional disclosures about the Company’s use of derivatives.